Showing results (101-110 of 183) with videos related to

Sort By:
Pageof 19
Archives of Gynecology and Obstetrics|November 27, 2010
Endometrial expression of estrogen receptor β and its splice variants in patients with and without endometriosisIngolf Juhasz-Böss, Claudia Fischer, Claus Lattrich, et al.
Mabs|May 30, 2014
Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodiesAnja K Wege, Marcus Schmidt, Elke Ueberham, et al.
Oncology Reports|June 20, 2012
Single nucleotide polymorphisms in the regulatory region of gonadotropin-releasing hormone receptor gene and breast cancer susceptibilityClaus Lattrich, Anna-Kristin Müller, Susanne Schüler, et al.
Acta Obstetricia Et Gynecologica Scandinavica|April 3, 2021
Contralateral lymph node metastases in patients with vulvar cancer and unilateral sentinel lymph node metastasesTanja Ignatov, Johannes Gaßner, Mihaela Bozukova, et al.
International Journal of Molecular Medicine|March 2, 2012
Estrogen receptor β transcript variants associate with oncogene expression in endometrial cancerJulia Häring, Maciej Skrzypczak, Anette Stegerer, et al.
Steroids|October 3, 2015
Molecular profiling of estrogen receptor α and progesterone receptor transcript variants in endometrial cancerMaciej Skrzypczak, Isabel Merx, Susanne Schüler-Toprak, et al.
European Journal of Epidemiology|January 25, 2021
Sedentary behaviour in relation to ovarian cancer risk: a systematic review and meta-analysisVeronika S Biller, Michael F Leitzmann, Anja M Sedlmeier, et al.
Gynecologic Oncology|July 27, 2019
Lymph node micrometastases and outcome of endometrial cancerAtanas Ignatov, Christin Lebius, Tanja Ignatov, et al.
Breast Cancer Research and Treatment|March 15, 2021
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastasesMadeleine Hetterich, Michael Gerken, Olaf Ortmann, et al.
Oncotarget|February 22, 2018
The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of diseaseGero Brockhoff, Stephan Seitz, Florian Weber, et al.
Pageof 19